Dr Lowan Stewart

Dr. Lowan Stewart is a specialist Emergency Physician and Fellow of the American College of Emergency Medicine. He has practiced in the United States and Norway since 2003 and completed his medical training at the University of New Mexico School of Medicine, UT Austin, and Oregon Health & Science University (OHSU). He later served as Emergency Department Chair at WF Hospital and as an Associate Clinical Professor at OHSU. Dr. Stewart played a key role in establishing Emergency Medicine as a recognized specialty in Norway, serving on the board of the Norwegian Society of Emergency Medicine. He is the co-founder of Insight Ketamine (2016), Axon Clinic (2018), and the first public ketamine treatment unitin Scandinavia at Sykehuset Østfold (2020). His research background includes work on the evolution of emotions, winter depression, complexity theory (Santa Fe Institute), space medicine (Russian Academy of Sciences), and international public health. His current interests focus on the use of novel psychoactive medicines formood disorders and addiction. Dr. Stewart is a medical consultant for PsykForsk, DPS Nordre Østfold, contributing to clinical trials with psilocybin, MDMA, ketamine, and esketamine. He advises public ketamine treatment centers across Norway, previously served as Regional Director for Awakn Life Sciences, and iscurrently the Medical Director of Axon Clinics. He is a founding member of the Norwegian Rapid-Acting Antidepressant Network (NORAAD), the psychedelic research group at the University of Oslo, and the Eating Disorder Lab at Oslo Nye Høyskole. Dr. Stewart also co-founded the Norwegian Association for Psychedelic Science, is an Expert Faculty Member of the American Society of Ketamine Physicians, and serves as an Associate Editor for the Journal of Psychedelic Studies.